Melanoma trials in China

In China 69 Also abroad 578

69 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
AMT-253 in Patients With Advanced Solid Tumours
Where
Beijing
Age
18 years and over
People
96
Run by
Multitude Therapeutics Inc.
See details and how to joinNCT06209580
Phase 1Taking people
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
15
Run by
Guangzhou FineImmune Biotechnology Co., LTD.
See details and how to joinNCT06942143
Phase 3Taking people
OH2 Injection in Melanoma
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Ürümqi, Weifang, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
340
Run by
Binhui Biopharmaceutical Co., Ltd.
See details and how to joinNCT05868707
Phase 1/2Taking people
OH2 Injection in Combination With HX008 for Melanoma.
Where
Beijing
Age
18 years to 75 years
People
60
Run by
Binhui Biopharmaceutical Co., Ltd.
See details and how to joinNCT04616443
Phase 4Not yet taking people in China
Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study
Where
Shijiazhuang
Age
18 years and over
People
40
Run by
Hebei Medical University Fourth Hospital
See details and how to joinNCT07004335
Phase 2Taking people
Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
Where
Shanghai
Age
18 years and over
People
58
Run by
Fudan University
See details and how to joinNCT06965231
Phase 1/2Taking people
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Where
Beijing
Age
18 years and over
People
50
Run by
Jun Guo
See details and how to joinNCT05983237
Phase 2Taking people
Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
Where
Beijing
Age
18 years to 75 years
People
60
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT05512481
Phase 2Not yet taking people in China
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
Where
Zhengzhou
Age
18 years to 75 years
People
20
Run by
YongZhang
See details and how to joinNCT06670300
Phase 2Not yet taking people in China
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
Where
Beijing, Changchun, Changsha, Hangzhou, Jinan, Shanghai, Taiyuan, Tianjin, Ürümqi, Zhengzhou
Age
18 years to 75 years
People
54
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06500091
Phase 3Taking people
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Where
Beijing
Age
18 years and over
People
165
Run by
Shanghai Kechow Pharma, Inc.
See details and how to joinNCT06008106
Phase 2/3Taking people
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Where
Guanzhou
Age
18 years and over
People
200
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739
No phaseTaking people
Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
Where
Beijing
Age
18 years to 100 years
People
50
Run by
Chinese PLA General Hospital
See details and how to joinNCT06203249
Phase 2Not yet taking people in China
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Where
Beijing
Age
18 years to 75 years
People
98
Run by
Convalife (Shanghai) Co., Ltd.
See details and how to joinNCT06183736
Phase 3Taking people
Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma
Where
Beijing
Age
18 years and over
People
140
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT05789043
Phase 1/2Not yet taking people in China
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
Where
Xi'an
Age
18 years to 75 years
People
48
Run by
Xijing Hospital
See details and how to joinNCT05539118
Phase 1Taking people
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
Where
Tianjin
Age
18 years and over
People
15
Run by
Suzhou BlueHorse Therapeutics Co., Ltd.
See details and how to joinNCT05366478
Phase 2Taking people
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
Where
Changchun
Age
18 years to 75 years
People
40
Run by
Di Wu
See details and how to joinNCT04331093
Phase 2Not yet taking people in China
Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma
Where
Beijing
Age
18 years to 75 years
People
26
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT04622566